Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19

Our main aim was to describe the effect on the severity of ACEI (angiotensin-converting enzyme inhibitor) and ARB (angiotensin II receptor blocker) during COVID-19 hospitalization. A retrospective, observational, multicenter study evaluating hospitalized patients with COVID-19 treated with ACEI/ARB....

Full description

Bibliographic Details
Main Authors: Emilia Roy-Vallejo, Aquilino Sánchez Purificación, José David Torres Peña, Beatriz Sánchez Moreno, Francisco Arnalich, María José García Blanco, José López Miranda, Juan Luis Romero-Cabrera, Carmen Rosario Herrero Gil, José Bascunana, Manuel Rubio-Rivas, Sara Pintos Otero, Verónica Martínez Sempere, Jesús Ballano Rodríguez-Solís, Ricardo Gil Sánchez, Jairo Luque del Pino, Amara González Noya, María Sierra Navas-Alcántara, Begoña Cortés Rodríguez, José Nicolás Alcalá, Ana Suárez-Lombraña, Jorge Andrés Soler, Ricardo Gómez-Huelgas, José Manuel Casas-Rojo, Jesús Millán Núñez-Cortés, on behalf of the SEMI-COVID-19 Network
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
ACEI
ARB
prognosis
MACE
Online Access:https://www.mdpi.com/2077-0383/10/12/2642

Internet

https://www.mdpi.com/2077-0383/10/12/2642

Similar Items